Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

TFC Therapeutics is a biotechnology company developing novel biologics to target and eliminate key drivers of cancer. The Company's emerging technology platform is focused on targeting and eliminating Tumor Macrophage Hybrid (TMH) cells. TMH cells are implicated in metastasis, treatment resistance, and relapse. TFC was founded by scientists and executives with deep cancer biology expertise and a commitment to delivering bene...
TFC Therapeutics is a biotechnology company developing novel biologics to target and eliminate key drivers of cancer. The Company's emerging technology platform is focused on targeting and eliminating Tumor Macrophage Hybrid (TMH) cells. TMH cells are implicated in metastasis, treatment resistance, and relapse. TFC was founded by scientists and executives with deep cancer biology expertise and a commitment to delivering benefits to patients based on the rigorous pursuit of novel approaches to cancer therapy.

List your booth number for exhibitions, ask us